INTRODUCTION
Ovigyn D 3 Tablet SR is a combination of medicines used to treat female infertility. It helps in maintaining the levels of sex hormones in the body and also works as an antioxidant, which further helps in proper cell growth and function.
Ovigyn D 3 Tablet SR may be used as supportive therapy in the treatment of various health conditions. It also provides benefits of a nutritional supplement. This medicine should be taken with food, preferably at a fixed time each day. There are no side effects associated with this medicine.
Pregnant or breastfeeding women should consult their doctor before starting treatment. You should also avoid drinking alcohol while you are taking this medicine.
USES OF OVIGYN D TABLET SR
- Female infertility
BENEFITS OF OVIGYN D TABLET SR
In Female infertility
Ovigyn D 3 Tablet SR contains a natural hormone that gets converted to estrogen (female sex hormone). It helps in the production and development of healthy eggs in women. This improves fertility in women and increases the chance of a successful pregnancy. Ovigyn D 3 Tablet SR reduces damage to egg cells, improves egg quality and thus enhances fertility. Taking Ovigyn D 3 Tablet SR helps maintain health and vitality in women.
SIDE EFFECTS OF OVIGYN D TABLET SR
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Ovigyn D
- No common side effects seen
HOW TO USE OVIGYN D TABLET SR
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ovigyn D 3 Tablet SR is to be taken with food.
HOW OVIGYN D TABLET SR WORKS
Ovigyn D 3 Tablet SR is a combination of three medicines: Dehydroepiandrosterone (Micronized), L-Methyl Folate and Vitamin D3. Dehydroepiandrosterone (Micronized) is a precursor of natural male and female sex hormones. L-Methyl Folate and Vitamin D3 provide essential nutrients.
Reviews
There are no reviews yet.